Eli Lilly net income set to rise

Eli Lilly &said net income will rise in 2005 as the pharmaceutical company wins approvals for drugs to treat diabetes, incontinence and depression.

Net income will increase to $2.80 to $2.90 a share from a forecast of $2.13 to $2.20 for this year, Lilly said in a statement yesterday before a meeting with analysts in New York. Sales will rise 8% to 10%, the company said.